Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0259879
Abstract: Purpose To analyze the risk factors associated with emerging intraocular inflammation (IOI) after intravitreal brolucizumab injection (IVBr) to treat age-related macular degeneration (AMD). Methods This study included 93 eyes of 90 patients. The incidence of… read more here.
Keywords: age; non ioi; ioi non; ioi ... See more keywords